Aclaris therapeutics to participate in the goldman sachs 45th annual global healthcare conference

Wayne, pa., june 06, 2024 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that dr. neal walker, interim president & ceo of aclaris, will participate in a fireside chat during the goldman sachs 45th annual global healthcare conference on tuesday, june 11, 2024 at 11:20 am et in miami, florida. a webcast of the fireside chat may be accessed through the “events” page of the “investors” section of aclaris' website, www.aclaristx.com.
ACRS Ratings Summary
ACRS Quant Ranking